Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge
- 13 September 2005
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 60 (6), 605-610
- https://doi.org/10.1111/j.1365-2125.2005.02499.x
Abstract
Methods to determine the lung delivery of inhaled bronchodilators from metered dose inhalers include urinary drug excretion 30 min post inhalation and methacholine challenge (PD20). We have compared these two methods to differentiate lung delivery of salbutamol from metered dose inhalers using different inhalation methods. In phase 1 of the study, on randomized study days, 12 mild asthmatics inhaled placebo, one and two 100 microg salbutamol doses from a breath actuated metered dose inhaler, in randomized fashion on different days. In phase 2, they inhaled one 100 microg salbutamol dose from a metered dose inhaler using a SLOW (20 l min(-1)) and a FAST (60 l min(-1)) inhalation technique and a slow inhalation delayed until after they had inhaled for 5 s (LATE). Urinary excretion of salbutamol (0-30 min) and PD20 were measured after each dose. Following placebo, one and two 100 microg salbutamol doses, the geometric mean for PD20 was 0.10, 0.41 and 0.86 mg respectively and the mean (SD) urinary drug excretion after one and two doses was 2.25 (0.65) and 5.37 (1.36) microg, respectively. After SLOW, FAST and LATE inhalations the geometric mean for PD20 was 0.50, 0.40 and 0.42 mg, respectively, and mean (SD) salbutamol excretion was 2.67 (0.84), 1.90 (0.70) and 2.72 (0.67) microg, respectively. Only the amount of drug excreted during the FAST compared with the SLOW and LATE inhalations showed a statistical difference (95% confidence interval on the difference 0.12, 1.54 and 0.06, 1.59 microg, respectively). Urinary salbutamol excretion but not PD20 showed differences between the inhalation methods used. When using a metered dose inhaler slow inhalation is better and co-ordination is not essential if the patient is inhaling when they actuate a dose of the drug.This publication has 21 references indexed in Scilit:
- Lung delivery of non‐CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizerBritish Journal of Clinical Pharmacology, 1998
- Differences in aerosol output and airways responsiveness between the DeVilbiss 40 and 45 hand held nebulisers.Thorax, 1995
- Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.Thorax, 1995
- Regulatory Aspects of Modifications to Innovator Bronchodilator Metered Dose Inhalers and Development of Generic SubstitutesJournal of Aerosol Medicine, 1994
- Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.Thorax, 1993
- Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response.Thorax, 1993
- Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique.Thorax, 1991
- Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma.Thorax, 1983
- Rapid method for measurement of bronchial responsiveness.Thorax, 1983
- Reproducibility and comparison of responses to inhaled histamine and methacholine.Thorax, 1978